Relation of nailfold capillaries and autoantibodies to mortality in patients with Raynaud’s phenomenon: a retrospective analysis
Rheumatology International · 2026
DOI: 10.1007/s00296-026-06261-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology International, 2026. Verfasst von Markus Müller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria. markus.a.mueller@meduniwien.ac.at. Hauptthemen laut MEDLINE: Raynaud Disease, Capillaries, Nails, Antibodies, Antinuclear. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.
Abstract (Originalsprache)
The presence of abnormal nailfold capillaries and antinuclear antibodies (ANA) is associated with increased all-cause mortality in patients presenting with incipient Raynaud’s phenomenon (RP). We conducted a retrospective analysis aiming to assess the association between abnormal nailfold capillaries, ANA, and mortality over a 20-year follow-up period. In 2958 patients with incipient RP without previously known connective tissue disease, nailfold capillaroscopies and laboratory tests for ANA and ANA-subsets were obtained. Of these, long-term follow-up data were available for 2922 patients. Over a median follow-up period of 23 (IQR 20.2–25.2) years, 832 patients died, of which 562 were women (25% of female patients) and 270 were men (41% of male patients). Compared to a demographically matched reference population, mortality was increased in female and male patients with RP (log-rank test < 0.001). In female patients with RP, the presence of ANA, anti-Scl-70 antibodies, and a grouping variable consisting of giant capillaries, reduced capillary density, and avascular fields was associated with an increase in all-cause mortality. The highest mortality was observed in patients presenting both abnormal nailfold capillaries and ANA. In the long-term, an excess mortality persists in patients with RP. Our study demonstrates prognostic associations between abnormal nailfold capillaries as well as ANA and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria. markus.a.mueller@meduniwien.ac.at.
- Division of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
- Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
- Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Förderung
- Medical University of Vienna
Zitieren
APA
Müller, M., Gschwandtner, M. E., Kiener, H., Perkmann, T., Zehetmayer, S., Brunner-Ziegler, S., Steiner, S., & Schlager, O. (2026). Relation of nailfold capillaries and autoantibodies to mortality in patients with Raynaud’s phenomenon: a retrospective analysis. Rheumatology International. https://doi.org/10.1007/s00296-026-06261-7
Vancouver
Müller M, Gschwandtner ME, Kiener H, Perkmann T, Zehetmayer S, Brunner-Ziegler S, et al. Relation of nailfold capillaries and autoantibodies to mortality in patients with Raynaud’s phenomenon: a retrospective analysis. Rheumatology International. 2026. doi:10.1007/s00296-026-06261-7
BibTeX
@article{Mller2026,
author = {Müller, Markus and Gschwandtner, Michael E and Kiener, Hans and Perkmann, Thomas and Zehetmayer, Sonja and Brunner-Ziegler, Sophie and Steiner, Sabine and Schlager, Oliver},
title = {Relation of nailfold capillaries and autoantibodies to mortality in patients with Raynaud’s phenomenon: a retrospective analysis},
journal = {Rheumatology International},
year = {2026},
doi = {10.1007/s00296-026-06261-7}
}
EUVIMED